Evidence map›Paper›PMID 39553058›Full record

ArticleCureus2024

The Itappachi Universal Motion Platform for Accurate Dose Measurement in Thoracoabdominal Radiotherapy.

Naoki Tohyama, Eriko Saito, Kazuhide Uchida, Kiyoshi Yoda, Shinichiro Mori

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Naoki TohyamaDepartment of Radiological Sciences, Komazawa University, Tokyo, JPN.
Eriko SaitoDepartment of Radiation Oncology, Tokyo Bay Makuhari Clinic for Advanced Imaging, Cancer Screening, and High-Precision Radiotherapy, Chiba, JPN.
Kazuhide UchidaCorporate Research and Development Center, Perfect Imaging Laboratory, Chiba, JPN.
Kiyoshi YodaCorporate Research and Development Center, Anzai Medical Co. Ltd., Tokyo, JPN.
Shinichiro MoriResearch Center, Perfect Imaging Laboratory, Chiba, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We developed the "Itappachi" universal motion platform for measuring radiation doses under simulated respiratory motion in radiation therapy. The interplay effect, resulting from respiratory motion, degrades dose delivery precision in advanced treatments such as volumetric modulated arc therapy. The Itappachi platform is designed for precise dose measurement in dynamic scenarios through its ability to simulate respiratory motion. The platform features a large surface (580 mm × 380 mm), capable of supporting weights up to 56.8 kg, and moves with an amplitude of ±25 mm. It requires no silicone oil for maintenance, and it is controlled via Wi-Fi using user-owned devices, thereby reducing costs. Its motion accuracy was confirmed, with a maximum displacement error of 0.12 mm. Using the platform, we conducted dose measurements with a Delta4 Phantom under static, moving without gated irradiation, and moving with gated irradiation conditions. Gamma index analysis revealed excellent agreement for static and dynamic gated conditions (99.4%), while significant dose degradation occurred in the non-gated dynamic condition (32.6%). The Itappachi platform provides a cost-effective and accurate solution for dose measurement under respiratory motion by which it supports improved quality assurance in radiation therapy.

Indexed as

dose measurementphoton beamradiation therapyrespiratory gatingvmat

Identifiers

PMID39553058
PMCPMC11568831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.